Baby Aspirin and Fertility: Can It Improve Implantation?

Published April 5, 2026 · 12 min read

By Dr. Emily Vasquez

Why TTC Communities Talk About Baby Aspirin

Scroll through any trying-to-conceive forum for more than a few minutes and you will encounter someone recommending baby aspirin. The advice usually sounds something like this: take an 81 mg aspirin every day to improve blood flow to your uterus and help the embryo implant. Sometimes the recommendation comes with citations. Sometimes it comes from someone who swears it was the one thing that made the difference after months of negative pregnancy tests.

The popularity of baby aspirin in the TTC community is not baseless. There is genuine clinical research behind the idea, most notably a large randomized controlled trial funded by the National Institutes of Health. But the conversation online tends to oversimplify the evidence, and the truth is more nuanced than a blanket recommendation for every woman trying to conceive.

This article examines the clinical evidence for low-dose aspirin and fertility, who is most likely to benefit, what the risks are, and how to have an informed conversation with your healthcare provider about whether it makes sense for you.

How Low-Dose Aspirin May Help Fertility

Aspirin belongs to a class of medications called nonsteroidal anti-inflammatory drugs (NSAIDs). At the low dose used in baby aspirin (81 mg), it works primarily as a blood thinner by inhibiting the enzyme cyclooxygenase-1 (COX-1), which reduces the production of thromboxane A2, a compound that promotes platelet aggregation and blood clotting.

There are three main mechanisms through which low-dose aspirin might support conception and early pregnancy:

Improved Uterine Blood Flow

For an embryo to implant successfully, the uterine lining needs an adequate blood supply. The endometrium must develop a rich network of blood vessels that will eventually support the placenta. By reducing platelet aggregation and mildly dilating blood vessels, low-dose aspirin may improve perfusion to the uterine lining. Several ultrasound studies have shown increased uterine artery blood flow in women taking low-dose aspirin, though the clinical significance of this finding is still debated.

Women with thin endometrial linings, a condition sometimes seen in women over 35 or those who have undergone uterine procedures, may particularly benefit from improved blood flow. A well-vascularized endometrium is more receptive to embryo implantation, which is why reproductive endocrinologists sometimes prescribe aspirin alongside IVF protocols.

Reduced Inflammation

Chronic low-grade inflammation can interfere with implantation. The immune system plays a carefully orchestrated role in early pregnancy, and excessive inflammatory signaling can disrupt the delicate balance needed for the uterus to accept an embryo. Low-dose aspirin reduces the production of prostaglandins and other inflammatory mediators, potentially creating a more hospitable environment for implantation.

This anti-inflammatory effect is particularly relevant for women with conditions that involve chronic inflammation, such as endometriosis, polycystic ovary syndrome (PCOS), or autoimmune conditions. These conditions are associated with elevated levels of inflammatory cytokines in the uterine environment, which may contribute to implantation failure or early pregnancy loss. Understanding how stress affects fertility is also important here, since chronic stress drives systemic inflammation.

Support for Implantation

Implantation is a complex process that requires the embryo to attach to the uterine wall, invade the endometrial tissue, and establish a blood supply from the mother. This process depends on adequate blood flow, appropriate immune modulation, and proper signaling between the embryo and the endometrium. By supporting the first two factors, aspirin may indirectly support the third.

If you are in the window between ovulation and your expected period, you may find it helpful to review the signs and symptoms of implantation so you know what to look for during this critical phase.

The EAGeR Trial: Key Findings

The most important study on low-dose aspirin and fertility is the Effects of Aspirin in Gestation and Reproduction (EAGeR) trial, a randomized, double-blind, placebo-controlled trial conducted by the National Institute of Child Health and Human Development (NICHD). This study enrolled 1,228 women aged 18 to 40 who had experienced one or two prior pregnancy losses and were actively trying to conceive.

Participants were randomly assigned to take either 81 mg of aspirin or a placebo daily, beginning before conception and continuing through week 36 of pregnancy if they conceived. The primary outcome was live birth.

The key findings, published in The Lancet, were as follows:

• Overall results: There was no statistically significant difference in live birth rates between the aspirin and placebo groups when looking at the entire study population. The live birth rate was 62 percent in the aspirin group versus 60 percent in the placebo group.
• Subgroup with single prior loss: Among women who had experienced only one prior pregnancy loss, aspirin was associated with a higher rate of pregnancy (78 percent vs. 66 percent) and a trend toward more live births, though the subgroup analysis requires cautious interpretation.
• Reduction in pregnancy loss: Women in the aspirin group who became pregnant experienced fewer pregnancy losses than the placebo group, particularly losses that occurred very early in pregnancy (chemical pregnancies).
• Implantation benefit: Aspirin was associated with a significant increase in the rate of implantation, as measured by hCG detection, suggesting that aspirin may help embryos implant that would otherwise fail to do so.

A secondary analysis of the EAGeR trial data found that aspirin was particularly beneficial for women who had experienced a pregnancy loss within the past year, women with higher levels of systemic inflammation (as measured by C-reactive protein), and women who adhered closely to the daily aspirin regimen.

Who Benefits Most from Baby Aspirin for Fertility

The evidence does not support recommending baby aspirin to every woman trying to conceive. The benefits appear to be concentrated in specific populations:

Women with a History of Pregnancy Loss

The strongest evidence comes from women who have experienced one or two early pregnancy losses. For these women, preconception aspirin may reduce the risk of another loss and improve the chances of a live birth. The American College of Obstetricians and Gynecologists (ACOG) has acknowledged the EAGeR trial data, though their primary aspirin recommendations focus on preeclampsia prevention.

Women with Inflammatory Conditions

Women with conditions associated with chronic inflammation, including PCOS, endometriosis, Hashimoto's thyroiditis, lupus, or other autoimmune conditions, may see greater benefit from aspirin's anti-inflammatory effects. The EAGeR trial subgroup analysis supported this, showing larger effects in women with elevated baseline inflammation.

Women with Thin Endometrial Lining

Some reproductive endocrinologists prescribe low-dose aspirin to women whose ultrasound monitoring reveals a thin endometrial lining (less than 7 mm at the time of expected implantation). The rationale is that improved blood flow may help the lining develop more fully, though randomized trial data specifically for this indication is limited.

Women Undergoing IVF or Medicated Cycles

Some fertility clinics include low-dose aspirin as part of their IVF protocols, particularly for women with a history of implantation failure. The evidence here is mixed. A Cochrane review found insufficient evidence to recommend aspirin routinely in IVF, but individual studies have shown benefit in specific subgroups.

Dosage and Timing for TTC

The dose used in virtually all clinical studies is 81 mg per day, which is the standard baby aspirin dose available over the counter. This is distinct from regular-strength aspirin (325 mg) or extra-strength aspirin (500 mg), both of which carry significantly higher risks and are not recommended for fertility purposes.

Based on the EAGeR trial protocol and other clinical data, the typical approach is:

• Start timing: Begin taking baby aspirin at the start of the menstrual cycle in which you are trying to conceive, ideally on cycle day 1. Some providers recommend starting even earlier, in the cycle before you begin actively trying.
• Daily dosing: Take one 81 mg aspirin daily, at the same time each day. Taking it with food can help reduce stomach irritation.
• Continue through the two-week wait: Do not stop aspirin during the two-week wait. In the EAGeR trial, women continued aspirin through pregnancy.
• If you become pregnant: Do not stop aspirin without consulting your healthcare provider. Many providers will continue low-dose aspirin through pregnancy, particularly for preeclampsia prevention in women with risk factors.
• If the cycle is negative: Continue into the next cycle. The EAGeR trial allowed up to six cycles of treatment.

Risks and Side Effects

Low-dose aspirin is one of the most widely studied medications in the world, and at 81 mg, serious side effects are uncommon. However, no medication is without risk, and it is important to be informed:

• Gastrointestinal irritation: Even at low doses, aspirin can irritate the stomach lining. Taking it with food and staying well hydrated reduces this risk. If you develop persistent stomach pain, stop taking it and consult your doctor.
• Increased bleeding tendency: Because aspirin inhibits platelet function, it can increase the tendency to bleed. This is usually minor (easier bruising, longer bleeding from small cuts) but can be significant for women with existing bleeding disorders or those taking other blood-thinning medications.
• Allergic reactions: Some people are allergic to aspirin. Symptoms can include hives, swelling, difficulty breathing, or asthma attacks. If you have ever had an allergic reaction to aspirin or other NSAIDs, do not take baby aspirin.
• Interaction with other medications: Aspirin can interact with other blood thinners (such as heparin or warfarin), certain antidepressants (SSRIs), and other NSAIDs like ibuprofen. Tell your doctor about all medications you are taking.
• Reye's syndrome: This is a concern in children, not adults. There is no risk of Reye's syndrome from adult use of low-dose aspirin.

Women who should not take baby aspirin include those with active peptic ulcers, bleeding disorders such as hemophilia or von Willebrand disease, aspirin allergy, severe liver or kidney disease, or a history of hemorrhagic stroke.

What Your Doctor Needs to Know

Before starting baby aspirin for fertility, it is important to have a conversation with your healthcare provider. Here is what to bring to that discussion:

• Your pregnancy history: Share details about any prior pregnancies, including losses, their timing, and any known causes.
• Inflammatory conditions: Mention any diagnoses related to chronic inflammation, autoimmune disease, or conditions like PCOS or endometriosis.
• Current medications: List everything you are taking, including supplements. Your provider needs to assess potential interactions.
• Family history: A family history of blood clotting disorders, preeclampsia, or recurrent pregnancy loss may influence the recommendation.
• Your TTC timeline: Let your provider know how long you have been trying, what methods you are using (including your preconception preparation), and whether you are using at-home insemination or planning clinic-based treatment.

Many obstetricians and reproductive endocrinologists are familiar with the EAGeR trial data. If your provider is not, you can reference the study by name (Effects of Aspirin in Gestation and Reproduction, published in The Lancet in 2014) to facilitate the conversation.

Combining Baby Aspirin with Other TTC Strategies

Baby aspirin is not a standalone fertility treatment. It works best as one component of a comprehensive approach to conception. Here are evidence-based strategies that complement aspirin therapy:

Prenatal Nutrition and Supplements

A well-formulated prenatal supplement provides the nutritional foundation for conception and early pregnancy. Folate, vitamin D, CoQ10, and omega-3 fatty acids all play roles in egg quality, endometrial health, and early embryonic development. Our Her Daily Formula is designed to deliver these key nutrients in their most bioavailable forms, complementing any additional interventions you and your provider decide on.

For a comprehensive overview of evidence-based supplements for fertility, see our guide to the best fertility supplements for TTC.

Ovulation Timing

No medication can overcome poor timing. Aspirin may improve the uterine environment, but sperm still needs to reach a viable egg. Accurate ovulation tracking using OPKs, basal body temperature, or cervical mucus monitoring remains the single most impactful thing you can do to improve your chances each cycle.

Stress Management

Chronic stress elevates cortisol and inflammatory markers, potentially undermining the very benefits aspirin provides. Incorporating stress reduction techniques such as mindfulness, moderate exercise, or therapy can support both your mental health and your fertility. Our article on stress and fertility explores the biological mechanisms and practical strategies in depth.

Comprehensive Cycle Support

For women who want a complete toolkit for each cycle, the Her Success Kit combines nutritional support with practical tools for timing and insemination, giving you everything you need in one place.

The Bottom Line

Baby aspirin is not a magic fertility pill, but the evidence suggests it may offer meaningful benefits for specific groups of women trying to conceive, particularly those with a history of early pregnancy loss, chronic inflammatory conditions, or thin endometrial linings. The EAGeR trial remains the most robust evidence available, and its findings support the use of preconception low-dose aspirin in women with one or two prior losses.

For women without these risk factors, the evidence is less compelling, and the decision to take aspirin should be made in consultation with a healthcare provider who understands your individual medical history. What is clear is that aspirin is inexpensive, widely available, and carries a low risk profile at the 81 mg dose, making it a reasonable addition to a fertility plan for many women after appropriate medical evaluation.

Whether you are in the early stages of your TTC journey or have been trying for several cycles, building a comprehensive approach that includes proper nutrition, accurate timing, stress management, and informed medical support gives you the strongest possible foundation for conception.

Frequently Asked Questions

Does baby aspirin help with implantation?

Low-dose aspirin may support implantation by improving blood flow to the uterine lining and reducing localized inflammation. The NIH EAGeR trial found that daily low-dose aspirin increased the live birth rate among women with a history of one or two pregnancy losses. However, the benefit was not seen in all populations, so it is important to discuss with your doctor whether aspirin is appropriate for your situation.

When should I start taking baby aspirin for fertility?

Most studies that showed a benefit had women begin taking low-dose aspirin before conception, typically starting at the beginning of the menstrual cycle in which they were trying to conceive. In the EAGeR trial, women began aspirin before pregnancy and continued through week 36 of gestation. Your healthcare provider can advise on the best timing for your individual circumstances.

Is baby aspirin safe while trying to conceive?

Low-dose aspirin (81 mg) is generally considered safe for most women trying to conceive. It has been widely studied in pregnancy and preconception settings. However, it is not appropriate for everyone. Women with bleeding disorders, aspirin allergies, active peptic ulcers, or certain other conditions should not take it. Always consult your doctor before starting any new medication.

Can baby aspirin prevent miscarriage?

The EAGeR trial demonstrated that preconception low-dose aspirin increased the likelihood of live birth in women who had experienced one or two prior pregnancy losses. However, aspirin has not been shown to prevent miscarriage in women without a history of loss or in women with recurrent miscarriage defined as three or more losses. The mechanism may involve improved uterine blood flow and reduced inflammation rather than preventing the chromosomal abnormalities that cause most miscarriages.